[ad_1] OAK BROOK, Ill., November 30, 2020 / PRNewswire / – Massachusetts General Hospital (MGH) researchers have developed a deep learning model that identifies imaging biomarkers on mammography screening to predict a patient’s risk of developing breast cancer more accurately than traditional assessment tools risk. The results of the study …
Read More »Haoma Medica completes first human trial for NaQuinate, a new treatment under development for osteoporosis
[ad_1] LONDON, November 26, 2020 / PRNewswire / – Haoma Medica today announced the completion of a first human study for NaQuinate, a naphthoquinone carboxylic acid, which is under development as a new orally administered drug for osteoporosis. The first human study launched last year in healthy adults investigated single …
Read More »Discovery of potential treatment against antibiotic-resistant bacteria that cause gonorrhea and meningitis
[ad_1] MONTREAL is LAVAL, November 24, 2020 / CNW Telbec / – A team from National Institute for Scientific Research (INRS) demonstrated the effectiveness of an inexpensive molecule to fight antibiotic-resistant strains of the bacteria responsible for gonorrhea and meningococcal meningitis. These two infections affect millions of people around the …
Read More »Innovent announces Phase I clinical trial results of IBI302, a first-class anti-VEGF and anti-complement ophthalmic recombinant human bi-specific fusion protein for age-related neovascular macular degeneration at 2020 AAO
[ad_1] SAN FRANCISCO and SUZHOU, China, November 15, 2020 / PRNewswire / – Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and markets high-quality medicines for the treatment of oncological, metabolic, autoimmune and other major diseases, announces that the results of Phase Clinical I The …
Read More »SSRI antidepressants may be effective early treatments for COVID-19
[ad_1] Researchers at Washington University School of Medicine in St. Louis published the results of a clinical trial evaluating an antidepressant, fluvoxamine, for early treatment for COVID-19. The study was published in JAMA, The Journal of the American Medical Association, and was funded by the COVID-19 Early Treatment Fund (CETF). …
Read More »Fauna Bio analyzes the broadest set of mammalian genomes to advance biomedical research
[ad_1] EMERYVILLE, California, November 11, 2020 / PRNewswire / – Bio Fauna today announced that the co-founder and Chief Technology Officer, Linda Goodman, is a co-author of a she studies Posted in Nature as part of an international team of researchers with an effort called the Zoonomia Project. The study, …
Read More »